Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dissecting RNA-interference pathway with small molecules.

Ya-Lin Chiu1, Chimmanamada U Dinesh, Chia-ying Chu

  • 1Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Chemistry & Biology
|June 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amide-functionalized cholic acid hybrids: design, bioactivity, and computational analysis.

RSC advances·2026
Same author

Eco-friendly reduced graphene oxide@potash alum-based composite membranes for efficient separation of dyes and selective removal of contaminants from wastewater.

RSC advances·2026
Same author

Seronegative Autoimmune Encephalitis Presenting With Severe Neuropsychiatric Symptoms in an Older Adult: A Case of Diagnostic Complexity.

Case reports in psychiatry·2026
Same author

Effects of a Tacrine Analogue on Behavioral and Biochemical Parameters in Drosophila melanogaster.

Chemistry & biodiversity·2026
Same author

Unraveling Protracted Neuropsychiatric Symptoms in a Patient With Altered Post-Bariatric Pharmacokinetics: A Diagnostic Puzzle.

Case reports in psychiatry·2026
Same author

ATP Hydrolysis Gates an Ultra-Rapid Unwinding Mode of AfXPB Revealed by DNA Electrochemistry.

Cell biochemistry and function·2026
Same journal

The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation.

Chemistry & biology·2017
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
See all related articles

Researchers identified ATPA-18, a novel small molecule that inhibits RNA interference (RNAi) by blocking short-interfering RNA (siRNA) unwinding. This discovery offers new tools for studying gene silencing and reverse genetics.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • RNA interference (RNAi) is a conserved biological process utilizing short-interfering RNAs (siRNA) for sequence-specific gene silencing.
  • Understanding the precise mechanisms and regulatory steps of RNAi is crucial for its application in research and therapeutics.

Purpose of the Study:

  • To identify and characterize small molecule inhibitors of the RNA interference pathway.
  • To investigate the role of siRNA unwinding in RNAi efficacy and timing.
  • To develop novel chemical tools for studying gene function through reverse genetics.

Main Methods:

  • Screening of a chemical library of substituted dihydropteridinones.
  • Biochemical assays and fluorescence resonance-energy transfer (FRET) experiments.

Related Experiment Videos

  • Analysis of target RNA cleavage by the RNA-induced silencing complex (RISC).

    • Main Results:

    • Identification of ATPA-18, a non-toxic, cell-permeable, and reversible inhibitor of RNAi in human cells.
    • ATPA-18 was shown to inhibit siRNA unwinding within 6 hours of transfection.
    • The compound demonstrated reduced target RNA cleavage by activated RISC, indicating inhibition upstream of or at the unwinding step.

    Conclusions:

    • siRNA unwinding is a critical, time-dependent step required for RNAi pathway function.
    • ATPA-18 represents a novel chemical probe for dissecting RNAi mechanisms.
    • ATPA-18 analogs hold promise for studying in vivo gene function via reverse genetics.